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ABSTRACT 
Smoking rates in people with depression and anxiety are twice as high as in the general population, 
even though people with depression and anxiety are motivated to stop smoking. Most healthcare 
professionals are aware that stopping smoking is one of the greatest changes that people can make 
to improve their health. However, smoking cessation can be a difficult topic to raise. Evidence 
suggests that smoking may cause some mental health problems, and that the tobacco withdrawal 
cycle partly contributes to worse mental health. By stopping smoking, a person’s mental health may 
improve, and the size of this improvement might be equal to taking anti-depressants. In this 
theoretical review and practical guide we outline ways in which healthcare professionals can raise 
the topic of smoking compassionately and respectfully to encourage smoking cessation. We draw on 
evidence-based methods like cognitive behavioural therapy, and outline approaches that healthcare 
professionals can use to integrate these methods into routine care.  
KEYWORDS  
Smoking cessation, anxiety, depression, cognitive behavioural therapy, theoretical review, practical 
guide 
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WHO IS THIS THEORETICAL REVIEW AND GUIDE FOR? 
This guide is for healthcare professionals who are involved in routine healthcare for people who have 
common mental health problems like anxiety, depression, low mood or stress, and who smoke 
tobacco. 
 
You could be a nurse, a psychological wellbeing practitioner, a psychiatrist, a GP, a therapist, or clinical 
psychologist, working in any healthcare setting where you have an opportunity to offer a brief or 
intensive behavioural intervention to encourage or support smoking cessation. 
 
You do not need to be an expert in tobacco addiction to use, read or apply this review and guide. 
INTRODUCTION 
Smoking tobacco is the world’s leading cause of preventable illness and death (World Health 
Organisation, 2011). One in every two smokers will die of a smoking-related disease, unless they stop 
smoking (Doll et al., 2004; Pirie et al., 2013). In the United Kingdom smoking prevalence has decreased 
from 46% during the 1970s to about 15% in recent years (West and Brown, 2019). However, in the UK 
approximately 34% of people with depression and 29% of people with anxiety, smoke tobacco (Taylor, 
Itani, et al., 2019). People with depression and anxiety are more heavily addicted, suffer from worse 
withdrawal (Royal College of Physicians and Royal College of Psychiatrists, 2013), and find it harder to 
quit (odds ratio 0.81, 95% confidence interval (CI): 0.67 to 0.97) (Hitsman et al., 2013). These 
inequalities at least partly contribute to a reduction in life-expectancy in people with mood disorders 
when compared to the general population (mortality rate ratio, 1.92 (95% CI 1.91 to 1.94) (Plana-
Ripoll et al., 2019).  
 
Most healthcare professionals are aware that stopping smoking is one of the greatest changes that 
people can make to improve their health. However, smoking cessation can be a difficult topic to 
raise. Many people say that smoking tobacco helps them to alleviate stress, cope with their mental 
health difficulties, like low mood or anxiety and that smoking brings them relaxation or pleasure 
(Malone, Harrison and Daker-White, 2018). When discussing smoking cessation, it can sometimes 
feel like we might be depriving people of one of their ‘biggest pleasures’. It can also feel like we 
might undermine our relationship with them, and their trust in us, which could compromise future 
consultations and treatment plans.  
 
Traditionally, tobacco addiction and mental health have been treated separately, usually focusing on 
mental health first (Baker et al., 2019). Research shows that people with mental health problems are 
as motivated to quit as the general population, with more than half contemplating quitting within 6 
months, or preparing to quit within 30 days (Richardson, McNeill and Brose, 2019). However, we 
know that for many people, mental health conditions can be recurring over the longer term. So, 
when is ‘the right time’ to quit smoking? People with mood disorders are most likely to die from 
smoking-related diseases (Plana-Ripoll et al., 2019). How best can we address smoking cessation 
when their main presenting concern is their mental health? 
 
It is not yet widely known that smoking tobacco might actually cause mental health problems (Taylor 
and Munafò, 2018), and that stopping smoking may improve mental health (Taylor et al., 2014, 
2020). In fact, the size of improvement in mental health observed when people stop smoking is 
similar to the size of effect observed when people take anti-depressants (Taylor et al., 2014). This 
improvement can be at least partly explained by breaking the tobacco withdrawal cycle. Tobacco 
addiction leads to periods of withdrawal shortly after having a cigarette, whereby the person who 
smokes experiences psychological symptoms such as low mood, anxiety, poor concentration and 
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irritability (Benowitz, 2010). If the person smokes on a regular basis they will feel these withdrawal 
symptoms much of the time, with short periods of relief only when they smoke, and shortly after.  
 
As healthcare professionals there are ways that we can compassionately approach smoking 
cessation and remain respectful of the person’s autonomy. It’s important that we share new 
research findings, reassuring patients that stopping smoking will not have a negative impact on their 
overall mental health and could actually improve it in the long term. This knowledge could empower 
and motivate smoking cessation. Smoking cessation treatments are effective in this population 
(Taylor, Itani, et al., 2019). However, as people with common mental health problems often 
experience higher levels of tobacco dependence, they can require higher doses over longer periods 
of time of some medicines, like NRT (NCSCT, 2019), and tailored behavioural support during their 
quit attempt (National Institute for Clinical Excellence (NICE), 2013), specifically targeting mood (van 
der Meer et al., 2013). 
Learning objectives 
Although the focus of this article is primarily on those with common mental health problems, this 
article may also be useful to guide consulting with patients who report stress, and other common 
mood disturbances. After reading this article you will be able to: 
1. Use principles from cognitive behaviour therapy (CBT) to help your clients with common 
mental health problems to understand how their tobacco dependence and mental health 
are linked; 
2. Understand how the tobacco withdrawal cycle, conditioned craving, and possible increases 
in side-effects of prescribed medications upon cessation can all mimic common mental 
health symptoms, like anxiety, depression, low mood or stress; and  
3. Understand how breaking the tobacco withdrawal cycle, better coping with cravings, and 
developing greater self-control can all improve mental health. 
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UNDERSTANDING COGNITIVE BEHAVIOUR THERAPY PRINCIPLES. 
The basic principles of cognitive behaviour therapy (CBT) are a helpful way to support clients to see 
how their thoughts, emotions, behaviour and physical sensations are interlinked (Figure 1). CBT is 
usually used to treat mental health conditions like anxiety, depression, low mood and stress, but can 
also be used to treat smoking and alcohol and other drug problems. Recently, a dual process theory 
of addiction has been proposed, whereby addictive behaviour is the result of the predominance of 
implicit, automatic, and mainly nonconscious cognitive processes over explicit, controlled, and 
mainly conscious processes (Heather and Segal, 2016). CBT helps people focus in on their present 
challenges and how these are linked with their thoughts, emotions, behaviour and physical 
sensations. Using this model can help people to recognise, assess and respond to their problems, by 
establishing greater behavioural and cognitive control over impulsive urges and preventing relapse 
(Heather and Segal, 2016). 
HOW DO I LINK MOOD AND OTHER EXPERIENCES OF MENTAL HEALTH SYMPTOMS AND SMOKING 
USING A CBT MODEL? 
Using a CBT model is a helpful way of supporting people to see how their thoughts, emotions, 
behaviour and physical sensations are interlinked in the context of their tobacco dependence and 
mental health (Figure 1). To promote smoking cessation for people with depression or anxiety, self-
monitoring of mental health symptoms and medication side-effects increases understanding about 
their links. Monitoring that starts pre-cessation and continues for a few weeks post-cessation may 
help to distinguish temporary nicotine withdrawal symptoms from a relapse of mental illness and, 
for those taking medication, can track common adverse side effects that can increase with quitting 
(Segan et al., 2017). Of course, monitoring can also help to address symptoms regardless of their 
cause.  
The monitoring tool used by Quitline Victoria (See Segan et al. (2017)) includes structured 
monitoring of: (i) nicotine withdrawal symptoms using the 8-item Minnesota Nicotine Withdrawal 
Scale (Hughes, 2007b) to examine: anger/irritability/frustration, anxiety or nervousness, 
depression/sad mood, desire/craving to smoke, difficulty concentrating, increased 
appetite/hunger/weight gain, insomnia/sleep problems/awakening at night, and 
restlessness/impatience, and (ii) the most common adverse side effects of psychiatric medications, 
i.e., dry mouth, increased thirst, drowsiness, tiredness, fatigue, increased sleep, blurred vision, 
dizziness, headache, increased sweating, increased salivation, and nausea (Lapshin, Skinner and 
Finkelstein, 2006). When administered, the scale is referred to as a “mood and experiences scale” 
because smokers might be confused by completing a “withdrawal” scale prior to cessation and 
sometimes post-cessation will not report a symptom if they do not believe that it is due to 
withdrawal. Use of the term “symptom” was avoided as it is very clinical and can imply that 
something is wrong and needs fixing; hence the phrase “moods and experiences” and “possible side 
effects.” There is of course some overlap between some nicotine withdrawal symptoms (anxiety, 
depression, increased appetite/weight gain, insomnia) and common medication side effects.  
In the case of anxiety, depression, low mood and stress, the five areas of the model can help us 
understand that these conditions and their associated feelings can be a trigger for smoking (Figures 
2 and 3). Smoking may be an effort to calm themselves down, reduce anxiety, make themselves feel 
relaxed, give themselves a break, or to self-medicate. As smoking provides short term relief from 
withdrawal, and as the person thinks they feel better after a cigarette, this reinforces their smoking 
behaviour. However, as little as 20 minutes later this cycle will happen again generating further 
feelings of anxiety, sadness or hopelessness, etc. Figures 2 and 3 show how these areas interact with 
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one another to maintain an unhelpful coping behaviour, or maintain a pattern of low mood. You can 
watch this animation available here summarising this approach https://youtu.be/HiYBGOQ-PIo. 
 
Showing your client this animation might be a useful tool when explaining links between tobacco use 
and depression/anxiety symptoms https://www.youtube.com/watch?v=iQn4MbWbiSU. 
HOW CAN I INTEGRATE CBT PRINCIPLES FOR SMOKING AND MENTAL HEALTH INTO ROUTINE 
CARE? 
These CBT principles are designed to be used as a tool, not as a sole treatment, and are best used as 
part of a NICE recommended smoking cessation treatment, ideally behavioural support in 
combination with pharmacotherapy for smoking cessation (National Institute for Clinical Excellence 
(NICE), 2018). Depending on time available and circumstances, behavioural support may range from 
very brief advice or behavioural support, or involve developing a collaborative model or 
‘formulation’ of the person’s smoking and a plan for cognitive and behavioural change involving such 
approaches as behavioural activation, mindfulness, coping with cravings and relapse prevention. 
Pharmacotherapy choice will depend on previous experience, preference, and whether or not the 
person will also consult a medical practitioner for a prescription. Pharmacotherapy may involve NRT 
(usually a combination of patch and one or more short-acting forms such as gum, lozenge, spray or 
vaporizer), varenicline, or bupropion (depending on country). Smokers may also want to try e-
cigarettes as a nicotine replacement product, which is supported by Public Health England (McNeill 
et al., 2018). Adherence to medications is important and this can be monitored along with mood and 
experiences to enhance discussion of how medication assists in alleviation of withdrawal discomfort. 
 
Very brief advice for smoking cessation 
The National Centre for Smoking Cessation and Training’s (NCSCT) “very brief advice” approach is 
being increasingly used. A systematic review and meta-analysis of brief opportunistic interventions 
for smoking cessation found that healthcare professionals can be more effective in promoting 
attempts to stop smoking by offering help to all smokers, rather than by offering assistance only to 
those who state that they want to stop smoking (Aveyard et al., 2012). Brief interventions in settings 
like primary care, can be very effective to improve lifestyle behaviours (Aveyard et al., 2016). 
 
Very brief advice (the 3 A’s) involves: 
1. ASK - establish smoking status. “Do you smoke tobacco cigarettes or roll-ups?” 
2. ADVISE - that the best way of stopping smoking is to use a combination of behavioural 
support and drug treatment. “Did you know that smoking cessation medicine plus smoking 
cessation counselling can double your chances of quitting?” 
3. ASSIST - provide a referral or offer behavioural support using the CBT model as a tool, and 
follow-up appointments. “Would you like to meet again to talk about smoking cessation 
options?”, “I can refer you to a smoking cessation specialist, if you like?” 
 
Smokers may say to you that they are “too stressed out to stop”, that they would like to “deal with 
their mental health problem before they stop smoking”, or that they “won’t be able to cope without 
cigarettes”. This may be an ideal opportunity to implement the CBT principles for smoking and 
mental health (Figures 2 and 3) to explore their mental health and tobacco dependence. This might 
encourage them to think about stopping smoking or even prompt a quit attempt.  
 
Standard behavioural support for smoking cessation 
If you are regularly consulting with the person, or are involved in offering behavioural support to 
change lifestyle behaviours, or are involved in the provision of behavioural support for smoking 
cessation, the CBT principles for smoking and mental health discussed here can be integrated into 
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the standard smoking cessation treatment programme designed by the NCSCT (NCSCT, 2019). For 
example, the NCSCT recommends that standard behavioural support for smoking cessation involves 
of 110 minutes of behavioural support over 6 sessions. Within each of these sessions, there are 
opportunities to provide support around any concerns the person is having about quitting smoking 
and their mental health, psychoeducational opportunities about the withdrawal cycle and mental 
health, and the mental health benefits of smoking cessation. 
 
In the ESCAPE trial (Taylor, Aveyard, et al., 2019), psychological wellbeing practitioners are 
integrating smoking cessation treatment into psychological services for common mental health 
problems, using a smoking cessation intervention checklist (Table 1). Using this checklist, they are 
tailoring the intervention content to the person’s needs. Psychological wellbeing practitioners 
dedicate time during each session to address the person’s beliefs about smoking and mental health, 
and tailor intervention components using their knowledge about smoking and mental health, and 
mental health and tobacco withdrawal. 
UNDERSTANDING LINKS BETWEEN THE TOBACCO USE AND COMMON MENTAL HEALTH 
PROBLEMS. 
When someone starts smoking, there are some rewarding effects of tobacco on mood and 
cognition. Social reasons, such as feelings of belonging, can also be important. Smoking is also used 
as an appetite suppressant. However, as the person becomes used to the effects of tobacco, these 
reasons for smoking tend to diminish as the alleviation of withdrawal symptoms like low mood, 
irritability, poor concentration, restlessness and anxiety (Benowitz, 2010) gain prominence. 
Nevertheless, the initial rewarding effects of smoking tend to remain important in the minds of 
smokers and it is these rewards that can tempt them back to smoking, even long after cessation has 
been achieved (Stevenson et al., 2017).  
 
Regular smoking causes neuroadaptations in nicotinic pathways in the brain. Neuroadaptations in 
these pathways are associated with occurrence of depressed mood, agitation and anxiety shortly 
after a cigarette is smoked (Benowitz, Hukkanen and Jacob, 2009). This withdrawal cycle is marked 
by fluctuations in a smoker’s psychological state throughout the day and can worsen mental health 
(Parrott, 2004). There is evidence some systems that are compromised during longer term tobacco 
exposure recover after smoking cessation (Mamede et al., 2007). 
 
People who smoke regularly will feel these withdrawal symptoms much of the time, with short 
periods of relief only when they smoke, and shortly after (Figure 4). When caught in this cycle, 
people can mistakenly believe that smoking helps relieve symptoms of anxiety or low mood (Parrott, 
2004). But this isn’t the case – these symptoms are caused by tobacco withdrawal. Stopping smoking 
will eventually alleviate these symptoms altogether. Improvements in these symptoms, usually start 
several weeks after stopping smoking, and then the cycle is broken (Hughes, 2007a; Taylor et al., 
2014). Lapses to smoking can be associating with recalling the initial pleasures associated with 
smoking or beliefs around dealing with stress. Lapses can be seen as learning opportunities towards 
eventual cessation.   
 
Tobacco use is a vicious cycle that can negatively affect mental health. It’s useful to explain this cycle 
to smokers with mental health problems. From here, you can then help them understand how their 
smoking and mental health are linked. This information can be formulated as part of their 
presentation and a clear understanding can be sought about how smoking can become a 
maintenance factor in their mental health difficulties. Figure 4 shows that 20 minutes after smoking 
a cigarette, levels of nicotine and other chemicals start to reduce (Benowitz, Hukkanen and Jacob, 
2009). This leads to physical and psychological tobacco withdrawal with symptoms such as – poor 
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concentration, insomnia, feelings of tension, restlessness, low mood and anxiety. You can see how 
most of these symptoms might be mis-attributed as mental health symptoms.  
CAN SMOKERS COPE WITHOUT TOBACCO? 
There are many reasons why people report smoking tobacco. People with mental health problems 
usually report smoking cigarettes to alleviate emotional problems and feelings of depression and 
anxiety, to stabilise mood, for relaxation and stress-relief (Malone, Harrison and Daker-White, 2018). 
 
Studies have followed people making a quit attempt and show that when they stop smoking their 
mental health improves and, conversely, when they relapse, their mental health worsens to where it 
was before (Taylor et al., 2014). Similarly, there is good evidence that taking up smoking early in 
adolescence is associated with developing depression and anxiety (Wu and Anthony, 1999; Jamal et 
al., 2011, 2012). 
Smoking cessation can increase the blood levels and hence side effects of some psychotropic 
medications as well as alcohol and caffeine (Segan et al., 2017). This is because the tar in cigarette 
smoke (not the nicotine) causes the body to break down some substances more quickly than usual. 
Nicotine and nicotine replacement therapies do not affect medication, caffeine, or alcohol levels in 
this way. Monitoring these side-effects with the person quitting smoking can be helpful and we 
describe how to do so below.  
WILL STOPPING SMOKING HARM MENTAL HEALTH? 
Stopping smoking will not harm mental health. Evidence to-date suggests that there may be a causal 
effect of smoking on mental health, such that starting smoking increases risk of depression and 
schizophrenia (Taylor and Munafò, 2018). A systematic review and meta-analysis of 26 longitudinal 
studies found that stopping smoking was also associated with long-term improvements in mental 
health similar in effect size to taking anti-depressants, and the benefit was at least as large in people 
with psychiatric conditions (Taylor et al., 2014). Another study found no consistent evidence that 
varenicline, an effective medicine for smoking cessation, was associated with greater odds of 
depression, neurotic disorder, antidepressant, or hypnotic/anxiolytic prescription in clients with or 
without mental health disorders (Taylor, Itani, et al., 2019). In general, this study found that 
varenicline was associated with improved mental health outcomes, such as reductions in anti-
depressant and anxiolytic prescriptions up to 2 years after taking medicine to stop smoking (Taylor, 
Itani, et al., 2019). 
WHAT ABOUT PATIENTS WITH COMORBID MENTAL HEALTH, TOBACCO DEPENDENCE AND 
COMORBID SUBSTANCE/ALCOHOL USE?  
In people with comorbid substance and/or alcohol use, smoking rates are more than double 
compared to people with similar demographic characteristics (Guydish et al., 2016). Importantly, 
many people who use substances and/or alcohol, and who smoke tobacco are motivated to quit 
smoking tobacco, but report lack of support (Gentry et al., 2017). 
 
Some studies show that cannabis co-use is associated with worse tobacco smoking cessation 
outcomes, compared with tobacco-only users (Abrantes et al., 2009; Schauer, King and McAfee, 
2017; Vogel et al., 2018; Weinberger et al., 2018; McClure et al., 2019). However, other studies show 
that cannabis use is not associated with tobacco cessation outcomes (Humfleet et al., 1999; 
Hendricks et al., 2012; Rabin et al., 2016). Similarly for alcohol, co-use is associated with worse 
smoking cessation outcomes compared with tobacco-only users (Humfleet et al., 1999; Van Zundert, 
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Kuntsche and Engels, 2012; Haug, Schaub and Schmid, 2014; Haug et al., 2017; Weinberger, 
Gbedemah and Goodwin, 2017); alcohol use is also associated with increased tobacco cravings, and 
vice-versa (Cooney et al., 2007; Verplaetse and McKee, 2017). Patients with alcohol or opioid 
dependence report several barriers to quitting smoking tobacco including anxiety, 
tension/irritability, and concerns about the ability to maintain abstinence from their primary 
substance of abuse (McHugh et al., 2017). Those who report more barriers to smoking cessation 
while using substances/alcohol report lower confidence in the ability to change their tobacco 
smoking behaviour (McHugh et al., 2017).  
 
Historically, substance/alcohol use and tobacco dependence are treated separately. However, more 
recently, there has been a movement towards interventions that target multi-morbidity, including 
dual tobacco and substance/alcohol use, and in people with common mental disorders (Kay-Lambkin 
et al., 2013; Baker, A, Kavanagh, D, Kay-Lambkin, F, Hunt, S, Lewin, T, Carr VJ, 2014; Apollonio, 
Philipps and Bero, 2016). A Cochrane review of interventions for tobacco use cessation in people in 
treatment for or recovery from substance use found that offering pharmacotherapy for smoking 
cessation increased tobacco abstinence (risk ratio (RR) 1.88, 95%CI 1.35 to 2.57), as did combined 
counselling and offering pharmacotherapy for smoking cessation (RR 1.74,95% CI 1.39 to 2.18) 
compared with usual care or no intervention. The review found that tobacco cessation interventions 
were associated with smoking cessation for people in substance use treatment (RR 1.99, 95% CI 1.59 
to 2.50) and people in recovery (RR 1.33, 95% CI 1.06 to 1.67), and for people with alcohol 
dependence (RR 1.47, 95% CI 1.20 to 1.81) and people with other drug dependencies (RR 1.85, 95% 
CI 1.43 to 2.40). Importantly there was no evidence that offering tobacco cessation interventions to 
people in drug dependence treatment or recovery impacted on abstinence from alcohol and other 
drugs (RR 0.97, 95% CI 0.91 to 1.03). 
HOW DO I DISCUSS SMOKING WITHOUT SEEMING DIDACTIC?  
Smoking cessation can be a sensitive topic. Linking the person’s smoking to their mental health 
issues and personal values can help to break down the barriers to discussion (Miller and Rollnick, 
2013). It’s important not to prematurely focus on smoking. Actively listen to the person’s main 
concerns (e.g., such as feelings of depression). Introduce smoking by asking open-ended questions 
about any possible links between smoking and their main concern (e.g., mood), “What links have 
you noticed between smoking and your moods?” Seek permission to provide information about 
these links (e.g., “I wonder if you’d be interested in hearing about recent research findings about how 
smoking effects mental health?”). Healthcare providers can also spend a few moments debunking 
the myths about smoking: “A lot of people think that smoking is a stress reliever, but most people 
when they stop feel less stressed. Research shows their mental health permanently improves”. After 
providing them with information (as outlined further in this guide), ask “What do you make of that?” 
Explore with them their concerns about how smoking may be influencing their own mental health. 
Most people have other concerns about smoking, so ask them, “What other concerns do you have? 
What concerns you the most?” You can start to move the person towards consideration of cessation 
by asking “What’s the next step?”. 
 
When people are not contemplating quitting in the foreseeable future, it can be worthwhile to open 
the conversation up, acknowledging the pleasures initially experienced in the early days of smoking, 
“Tell me some of the reasons you smoke”. Often people will reply that although they did once enjoy 
being seen as ‘cool’ or part of the social crowd smoking whilst out drinking, they are likely to admit 
that such pleasures have been long outweighed by concerns such as addiction and cost. Reflect back 
on these concerns. If no concerns are mentioned, ask “Tell me what reasons you might have to want 
to quit?” Here, the person’s values may be raised, for example, many people talk about wanting to 
be good parents, to be around to see their children grow up and want to be available for family 
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members. Normalising the person’s feelings can help, for example, “That’s a common concern”. It’s 
important to encourage the person and boost their confidence in their ability to quit, “Did you know 
that you can double your chances of quitting with help from our local stop smoking services?” Health 
professionals can also spend a few moments debunking the myths about smoking, asking, “Can I tell 
you a few things about smoking that might surprise you and help you to quit?”, “I wonder, did you 
know that quitting smoking can improve your overall mental health?”, “Many people think it’s the 
nicotine in cigarettes that’s harmful, however, It’s the components in the tobacco smoke that are the 
most harmful”.  
CONCLUSION 
Most healthcare professionals are aware that stopping smoking is one of the greatest changes that 
people can make to improve their health. However, smoking cessation can be a difficult topic to 
raise, especially when a person’s main reason for consulting is their mental health, or another health 
concern. Evidence suggests that smoking may cause some mental health problems, and that the 
tobacco withdrawal cycle partly contributes to worse mental health. By stopping smoking, a person’s 
mental health may improve, and the size of this improvement might be equal to taking anti-
depressants. By drawing on evidence-based methods such as behavioural support and CBT 
healthcare professionals can address smoking cessation in a compassionate and respectful manner 
and successfully integrate smoking cessation treatment into routine care.   
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MULTIPLE CHOICE QUESTIONS 
1. The best way to support smoking cessation for people with common mental health 
problems is: 
a) To recommend that they try to quit once their mental health improves 
b) To recommend combination smoking cessation medicine, and behavioural support for 
smoking cessation 
c) Suggest that they use will power and nicotine replacement therapy 
d) Suggest that they go to their pharmacy for over-the-counter nicotine replacement 
therapy 
e) Not to recommend smoking cessation as smoking tobacco offers stress relief  
 
2. What do the 3 A’s stand for: 
a) Ask, Advise, Assist 
b) Avoid, Advise, Assist 
c) Argue, Advise, Assist 
d) Ask, Assess, Assist 
e) Aid, Assess, Advise 
 
3. How soon after smoking a cigarette do tobacco withdrawal symptoms start: 
a) 1 hour 
b) 24 hours 
c) 20 minutes 
d) 2-3 hours 
e) 12 hours 
 
4. Generally, quitting smoking is associated with: 
a) Worse mental health recovery 
b) Inability to cope with mental health symptoms 
c) Long term improvements in common mental health symptoms 
d) Needing a higher dose of anti-depressants 
e) None of the above 
 
5. Smoking is a risk factor in the development of: 
a) Cancers, and heart disease 
b) Depression 
c) Schizophrenia 
d) Poor quality of life 
e) All of the above 
ANSWERS 
1. The best way to support smoking cessation for people with common mental health 
problems is: 
a) F 
b) T 
c) F 
d) F 
e) F 
 
2. What do the 3 A’s stand for: 
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a) T 
b) F 
c) F 
d) F 
e) F 
 
3. How soon after smoking a cigarette do tobacco withdrawal symptoms start: 
a) F 
b) F 
c) T 
d) F 
e) F 
 
4. Generally, quitting smoking is associated with: 
a) F 
b) F 
c) T 
d) F 
e) F 
 
5. Smoking is a risk factor in the development of: 
a) F 
b) F 
c) F 
d) F 
e) T  
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